199 related articles for article (PubMed ID: 7649406)
1. Evidence from transgenic mice that myc regulates hepatic glycolysis.
Valera A; Pujol A; Gregori X; Riu E; Visa J; Bosch F
FASEB J; 1995 Aug; 9(11):1067-78. PubMed ID: 7649406
[TBL] [Abstract][Full Text] [Related]
2. Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver.
Ferre T; Riu E; Bosch F; Valera A
FASEB J; 1996 Aug; 10(10):1213-8. PubMed ID: 8751724
[TBL] [Abstract][Full Text] [Related]
3. Prevention of diabetic alterations in transgenic mice overexpressing Myc in the liver.
Riu E; Bosch F; Valera A
Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2198-202. PubMed ID: 8700908
[TBL] [Abstract][Full Text] [Related]
4. Glucose metabolism in transgenic mice containing a chimeric P-enolpyruvate carboxykinase/bovine growth hormone gene.
Valera A; Rodriguez-Gil JE; Yun JS; McGrane MM; Hanson RW; Bosch F
FASEB J; 1993 Jun; 7(9):791-800. PubMed ID: 8330686
[TBL] [Abstract][Full Text] [Related]
5. Correction of diabetic alterations by glucokinase.
Ferre T; Pujol A; Riu E; Bosch F; Valera A
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7225-30. PubMed ID: 8692973
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of c-myc in the liver prevents obesity and insulin resistance.
Riu E; Ferre T; Hidalgo A; Mas A; Franckhauser S; Otaegui P; Bosch F
FASEB J; 2003 Sep; 17(12):1715-7. PubMed ID: 12958186
[TBL] [Abstract][Full Text] [Related]
7. Vanadate normalizes hyperglycemia and phosphoenolpyruvate carboxykinase mRNA levels in ob/ob mice.
Ferber S; Meyerovitch J; Kriauciunas KM; Kahn CR
Metabolism; 1994 Nov; 43(11):1346-54. PubMed ID: 7968588
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus.
Valera A; Pujol A; Pelegrin M; Bosch F
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):9151-4. PubMed ID: 8090784
[TBL] [Abstract][Full Text] [Related]
9. Regulated expression of human insulin in the liver of transgenic mice corrects diabetic alterations.
Valera A; Fillat C; Costa C; Sabater J; Visa J; Pujol A; Bosch F
FASEB J; 1994 Apr; 8(6):440-7. PubMed ID: 8168695
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of c-myc in diabetic mice restores altered expression of the transcription factor genes that regulate liver metabolism.
Riu E; Ferre T; Mas A; Hidalgo A; Franckhauser S; Bosch F
Biochem J; 2002 Dec; 368(Pt 3):931-7. PubMed ID: 12230428
[TBL] [Abstract][Full Text] [Related]
11. The repression of hormone-activated PEPCK gene expression by glucose is insulin-independent but requires glucose metabolism.
Scott DK; O'Doherty RM; Stafford JM; Newgard CB; Granner DK
J Biol Chem; 1998 Sep; 273(37):24145-51. PubMed ID: 9727036
[TBL] [Abstract][Full Text] [Related]
12. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c.
Hagiwara A; Cornu M; Cybulski N; Polak P; Betz C; Trapani F; Terracciano L; Heim MH; Rüegg MA; Hall MN
Cell Metab; 2012 May; 15(5):725-38. PubMed ID: 22521878
[TBL] [Abstract][Full Text] [Related]
13. c-Myc is required for the glucose-mediated induction of metabolic enzyme genes.
Collier JJ; Doan TT; Daniels MC; Schurr JR; Kolls JK; Scott DK
J Biol Chem; 2003 Feb; 278(8):6588-95. PubMed ID: 12480946
[TBL] [Abstract][Full Text] [Related]
14. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
15. Hormonal regulation of liver phosphoenolpyruvate carboxykinase and glucokinase gene expression at weaning in the rat.
Girard J; Perdereau D; Narkewicz M; Coupé C; Ferré P; Decaux JF; Bossard P
Biochimie; 1991 Jan; 73(1):71-6. PubMed ID: 2031960
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of c-Myc in beta-cells of transgenic mice causes proliferation and apoptosis, downregulation of insulin gene expression, and diabetes.
Laybutt DR; Weir GC; Kaneto H; Lebet J; Palmiter RD; Sharma A; Bonner-Weir S
Diabetes; 2002 Jun; 51(6):1793-804. PubMed ID: 12031967
[TBL] [Abstract][Full Text] [Related]
17. Normalization of prandial blood glucose and improvement of glucose tolerance by liver-specific inhibition of SH2 domain containing inositol phosphatase 2 (SHIP2) in diabetic KKAy mice: SHIP2 inhibition causes insulin-mimetic effects on glycogen metabolism, gluconeogenesis, and glycolysis.
Grempler R; Zibrova D; Schoelch C; van Marle A; Rippmann JF; Redemann N
Diabetes; 2007 Sep; 56(9):2235-41. PubMed ID: 17596404
[TBL] [Abstract][Full Text] [Related]
18. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression.
Zhang W; Patil S; Chauhan B; Guo S; Powell DR; Le J; Klotsas A; Matika R; Xiao X; Franks R; Heidenreich KA; Sajan MP; Farese RV; Stolz DB; Tso P; Koo SH; Montminy M; Unterman TG
J Biol Chem; 2006 Apr; 281(15):10105-17. PubMed ID: 16492665
[TBL] [Abstract][Full Text] [Related]
19. Glucokinase and cytosolic phosphoenolpyruvate carboxykinase (GTP) in the human liver. Regulation of gene expression in cultured hepatocytes.
Iynedjian PB; Marie S; Gjinovci A; Genin B; Deng SP; Buhler L; Morel P; Mentha G
J Clin Invest; 1995 May; 95(5):1966-73. PubMed ID: 7738162
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms by which liver-specific PEPCK knockout mice preserve euglycemia during starvation.
She P; Burgess SC; Shiota M; Flakoll P; Donahue EP; Malloy CR; Sherry AD; Magnuson MA
Diabetes; 2003 Jul; 52(7):1649-54. PubMed ID: 12829628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
